FDA’s Draft Guidance Targets Allergen Cross-Contact and Undeclared Allergens in Food Manufacturing

In the ever-evolving sector of Food & Beverage, keeping pace with the latest litigation and regulatory updates is critical for legal professionals. October 2023 has introduced a significant change under the aegis of the U.S. Food and Drug Administration (FDA).

The FDA has unveiled its updated draft guidance aimed at assisting food manufacturers in aligning with the requirements for current good manufacturing practices (GMPs) and preventive controls for human food. The primary objective behind this updated draft guidance is to help mitigate the issue of allergen cross-contact and undeclared allergens.

Food allergen cross-contact refers to the unintentional incorporation of food allergens into a product. This can happen in a variety of ways such as shared equipment or processing lines with allergenic foods. Undeclared allergens on the other hand refer to any allergen not declared on the product’s label, which poses a serious concern for individuals with food allergies. This initiative by FDA, thus, brings forth a substantial and necessary approach towards food safety and the wellbeing of consumers.

These potential changes in the Food & Beverage industry could have profound implications for corporations and law firms in the sector. Keeping abreast of these developments is vital to understanding possible impacts on ongoing and future cases, preparing for any regulatory changes, and aligning operations and client services accordingly.

It’s worth noting that this is draft guidance, and the ultimate form and content of the final legislation or regulation may differ somewhat. As always, legal professionals are encouraged to monitor general trends as well as specific developments to ensure they are on top of any changes in the regulatory landscape. Considering the broad implications of these updates, legal professionals in the Food & Beverage industry could find much to discuss around these proposed changes.